Background: Various countries require blood donor screening using assays ap
plying specific HTLV-I and HTLV-II antigens. We evaluated the sensitivity a
nd specificity of 4 anti-HTLV-I + II ELISAs (Abbott, Murex, Organon Teknika
and Ortho). Methods: Panel A consisted of HTLV-I-positive individuals (n =
41), panel B of Mixed Titer Performance Panel 204 (Boston Biomedica Inc. p
anels C and D of dilution series from HTLV-I-positive (n = 30) and HTLV-II-
positive (n = 20) individuals and panel E of sera from first-time blood don
ors (n = 1,055). Results: In HTLV-I- and -II-positive samples, a sensitivit
y of 100% could be observed in all 4 ELISAs. In diluted HTLV-I- and -II-pos
itive samples, probit analysis revealed that the Murex assay had the highes
t analytical sensitivity, followed by the ELISAs from Ortho, Abbott and Org
anon Teknika. In specimens from first-time donors, a specificity of 100% wa
s observed in ELISAs from Murex, Organon Teknika and Ortho, and of 99.7% in
the assay from Abbott. Conclusion: The 4 anti-HTLV-I + II ELISAs studied w
ere appropriate as screening tests.